• Ten steps to investigate a cellular system with Mathematical modeling

    Ten steps to investigate a cellular system with Mathematical modeling

    Jasia King and Kerbaï Saïd Eroumé of MERLN Institute of Maastricht University have published the article “Ten steps to investigate a cellular syste...
  • Why Definitions Matter and Why We May Need One for Embryo-Like Structures

    Why Definitions Matter and Why We May Need One for Embryo-Like Structures

    Think of a cube. What is its size? What is its color? What is the structure of its surface like? Is the cube solid or hollow? Is it tiny or massive...
  • 56 million euros from National Growth Fund

    56 million euros from National Growth Fund

    Maastricht, April 9, 2021 – Today the Dutch cabinet decided to fully fund the National Growth Fund application of RegMed XB. A maximum of 56 millio...
  • Day two: First Townhall meeting RegMed XB successful!

    Day two: First Townhall meeting RegMed XB successful!

    Last Thursday 11 and Friday 12 March 2021, RegMed XB’s first online Townhall Event took place instead of the planned Annual Meeting. Read more abou...
  • Day one: First Townhall meeting RegMed XB successful!

    Day one: First Townhall meeting RegMed XB successful!

    Last Thursday 11 and Friday 12 March 2021, RegMed XB’s first online Townhall Event took place instead of the planned Annual Meeting. Read more abou...
  • Next building block for cartilage production

    Next building block for cartilage production

    Scinus Cell Expansion BV, a RegMed XB partner, has made the next step in bringing solutions to patients. Prometheus at KU Leuven, Belgium, installe...
  • Damage-Associated Molecular Patterns in Myocardial Infarction and Heart Transplantation: The Road to Translational Success

    Damage-Associated Molecular Patterns in Myocardial Infarction and Heart Transplantation: The Road to Translational Success

    Selma Kaffka genaamd Dengler, Clémence Odille, Mudit Mishra, Niels van der Kaaij, Pieter Doevensdans, Joost Sluijter and Saskia de Jager from the U...
  • First investment in potential medicine for stroke by FIRST-fund

    First investment in potential medicine for stroke by FIRST-fund

    The Utrecht-based company TargED Biopharmaceuticals received the first start-up funding from the FIRST fund, founded by the DCVA, RegMed XB and RVO...
  • The Ethics of Synthetic Embryology: A Blessing or a Curse?

    The Ethics of Synthetic Embryology: A Blessing or a Curse?

    “Should human embryo-like structures be considered human embryos? If not, do they resemble human embryos so closely that they should still be due s...
  • One step closer to therapies based on cartilage regeneration

    One step closer to therapies based on cartilage regeneration

    Congratulations to Margot Rikkers on the publication of the paper “Importance of Timing of Platelet Lysate-Supplementation in Expanding or Rediffer...
  • “Renal replacement therapy in Regenerative Medicine”

    “Renal replacement therapy in Regenerative Medicine”

    Thomas Geuens, Vanessa LaPointe and Clemens van Blitterswijk from MERLN Institute of Maastricht University have published the paper “Overcoming kid...
  • RegMed XB column in the Dutch patient magazine “Wisselwerking”

    RegMed XB column in the Dutch patient magazine “Wisselwerking”

    Within RegMed XB’s Kidney Moonshot work is done towards repairing kidneys or even growing new kidneys. The members of the Dutch patient associatio...
  • An ex vivo human osteochondral culture model

    An ex vivo human osteochondral culture model

    Congratulations to Meike W.A. Kleuskens on the publication of her paper “An ex vivo human osteochondral culture model” in the Journal of Orthopaedi...
  • More advances in research on kidney organoids

    More advances in research on kidney organoids

    Congratulations to Cathelijne W. van den Berg, on the publication of her paper “In Vivo Assessment of Size-Selective Glomerular Sieving in Transpla...
  • High potential of renal organoids and tubuloids in the treatment of kidney diseases

    High potential of renal organoids and tubuloids in the treatment of kidney diseases

    Researches from Hubrecht Institute and University Medical Center Utrecht, in collaboration with Radboud University Medical Center have recently pub...
  • Great step forward in the Dutch regenerative medicine field

    Great step forward in the Dutch regenerative medicine field

    Leiden University Medical Center (LUMC), one of RegMed XB’s founding partners, has recently announced the construction of the largest non-profit st...
  • New pro-bono collaboration with Trailblazers

    New pro-bono collaboration with Trailblazers

    Recently, a pro bono collaboration between RegMed XB’s Cardiovascular Moonshot and the software development company Trailblazers has started. Trail...
  • The work goes on

    The work goes on

    Despite the rules imposed by the coronacrisis, our Moonshot projects are still going strong! This month we held a series of online Progress meeting...
  • RegMed XB 2020 Annual Meeting

    RegMed XB 2020 Annual Meeting

    The second RegMed XB’s Annual Meeting was held in the Dutch National Railway Museum in Utrecht on 4 and 5 March. They were certainly very intense a...
  • Launch of FIRST investment fund

    Launch of FIRST investment fund

    Launch of FIRST investment fund to accelerate development of solutions for prevention and cure of chronic diseases ensuring patients benefit earlie...
  • RegMed XB welcomes new General Director, Bernard Mulder

    RegMed XB welcomes new General Director, Bernard Mulder

    The Supervisory Board of RegMed XB is excited to announce the appointment of Bernard Mulder as General Director, effective March 1, 2020. Bernard j...
  • First beating heart experiments outside the body

    First beating heart experiments outside the body

    The Dutch newspaper Algemeen Dagblad has published an article on the Cardiovascular Moonshot. For this article, an experiment at the laboratory of ...
  • €8 million impulse for regenerative and cardiovascular medicine

    €8 million impulse for regenerative and cardiovascular medicine

    Collaboration between researchers and venture capitalists accelerates innovation A collaboration between Regenerative Medicine Crossing Borders (Re...
  • Biomedica On The Move

    Biomedica On The Move

    You are cordially invited for the 1st edition of Biomedica On The Move on Valorisation in Regenerative Medicine October 10, 2019 12.00 - 18.30 pm B...
  • RegMed XB Annual Meeting 2019 photos

    RegMed XB Annual Meeting 2019 photos

    RegMed XB Annual Meeting 2019 visual impression 6 and 7 February 2019 RegMed XB organised its first annual meeting with numerous lectures and works...
  • RegMed XB Researchers build mini-kidneys from urinary cells

    RegMed XB Researchers build mini-kidneys from urinary cells

    Scientists from Utrecht University, University Medical Center Utrecht and Hubrecht Institute have successfully created kidney organoids from urine ...
  • RegMed XB start nieuwe moonshot voor hart- en vaatziekten

    RegMed XB start nieuwe moonshot voor hart- en vaatziekten

    RegMed XB organiseert op 6 en 7 februari haar jaarlijkse bijeenkomst met talloze lezingen en workshops. Speciale aandacht is er voor een nieuwe moo...
  • Letter of Commitment Signed

    Letter of Commitment Signed

    RegMed XB accelerates the development of therapies for four chronic diseases Funding for the establishment of an industry for regenerative medicine...
  • Dutch-Flemish Memo of Understanding

    Dutch-Flemish Memo of Understanding

    Industrial Platform for Regenerative Medicineupscaling to affordable cure for chronic diseases As part of the political summit between the Netherla...
  • Automation Entrepreneurs Receive Regional Subsidy

    Automation Entrepreneurs Receive Regional Subsidy

    Dutch Startup Nestegg Biotech B.V. has been awarded the "Limburg Makers Innovation Project" subsidy to fund development of Obruza laboratory automa...
  • Update: International Conference of Tissue-Engineered Heart Valves

    Update: International Conference of Tissue-Engineered Heart Valves

    The first International Conference of Tissue Engineered Heart Valves (ICTEHV) is being held on May 18th 2018. Our expert speakers and the wide rang...
  • 3rd NanoBio Surfaces and Interfaces in Healthcare and Science Workshop

    3rd NanoBio Surfaces and Interfaces in Healthcare and Science Workshop

    3rd NanoBio Surfaces and Interfaces in Healthcare and Science Workshop May 8-9, 2018 EPFL, Lausanne, Switzerland Chair: Prof. Philippe Renaud (EPFL...
  • Dokters van morgen

    Dokters van morgen

    Di 14 nov 21:25 • AVROTROS • 50 min RegMed XB wordt behandeld in de populaire documentaire-reeks Dokters van morgen.In de laatste aflevering van ee...
  • Vlaamse subsidiëring samenwerkingsprojecten regeneratieve geneeskunde

    Vlaamse subsidiëring samenwerkingsprojecten regeneratieve geneeskunde

    Subsidiëring samenwerkingsprojecten regeneratieve geneeskunde De Vlaams-Nederlandse topontmoeting in 2016 leidde tot afspraken over de versterking,...
  • RegMed XB Global Launch

    RegMed XB Global Launch

    Growth towards a 'worldwide-consortium' accelerates healing for the chronically ill RegMed XB is working on new scaling up in Europe and the US Reg...
  • August Newsletter

    August Newsletter

    Dear all,As RegMed XB is going ahead full force, we are happy to provide you with regular updates on our accomplishments. Here you can download our...
  • Binnen tien jaar nierfalen, diabetes en artrose genezen

    Binnen tien jaar nierfalen, diabetes en artrose genezen

    Volksziekten te lijf door René Steenhorst Nederlandse medische wetenschappers willen de komende tien jaar drie omvangrijke chronische ziekten genez...
  • RegMed XB in De Limburger (in Dutch)

    RegMed XB in De Limburger (in Dutch)

    Read the document published on delimburger.nl
  • RegMed XB press release

    RegMed XB press release

    Robust new institute for regenerative medicine The Netherlands and Belgium are working on a world-class institute for innovation RegMed XB is the n...

Have something to share?

Now you can contribute to keep our news section fresh and up-to date with relevant events and grants, research results and high impact publications related to REGMED XB’ Moonshots. Contributions can be sent to This email address is being protected from spambots. You need JavaScript enabled to view it.. Please submit the text in English and include a short title. We are looking forward to your input!

  • Diabetes FondsDiabetes Fonds
  • Leids Universitair Medisch CentrumLeids Universitair Medisch Centrum
  • Provincie UtrechtProvincie Utrecht
  • RijksoverheidRijksoverheid
  • Health HollandHealth Holland
  • Maastricht UMC+Maastricht UMC+
  • Provincie LimburgProvincie Limburg
  • TU/eTU/e
  • NierstichtingNierstichting
  • Provincie Noord-BrabantProvincie Noord-Brabant
  • Universiteit LeidenUniversiteit Leiden
  • LeidenLeiden
  • Stichting DONStichting DON
  • ReumaNederlandReumaNederland
  • Maastricht UniversityMaastricht University
  • UMC UtrechtUMC Utrecht
  • Utrecht UniversityUtrecht University
  • KU LeuvenKU Leuven
  • VIBVIB
  • HartstichtingHartstichting
  • 300Microns300Microns
  • Access2boneAccess2bone
  • Chemelot InSciTeChemelot InSciTe
  • Cyto smartCyto smart
  • Dutch CardioVascular AllianceDutch CardioVascular Alliance
  • Flanders State of the ArtFlanders State of the Art
  • FUJIFILMFUJIFILM
  • GalápagosGalápagos
  • HCM MedicalHCM Medical
  • Kuros BiosciencesKuros Biosciences
  • LifeTec GroupLifeTec Group
  • MateriomicsMateriomics
  • MimetasMimetas
  • Ministerie van Economische Zaken en KlimaatMinisterie van Economische Zaken en Klimaat
  • Ministerie van Onderwijs Cultuur en WetenschapMinisterie van Onderwijs Cultuur en Wetenschap
  • Ministerie van Volksgezondheid, Welzijn en SportMinisterie van Volksgezondheid, Welzijn en Sport
  • NcardiaNcardia
  • Nestegg BiotechNestegg Biotech
  • NTrans TechnologiesNTrans Technologies
  • Ostheo PharmaOstheo Pharma
  • Provincie Zuid-HollandProvincie Zuid-Holland
  • ScinusScinus
  • Starfish InnovationsStarfish Innovations
  • StentitStentit
  • SupraPolixSupraPolix
  • veldlaserveldlaser
  • VisualsonicsVisualsonics
  • XeltisXeltis

Information for

Contact information

  • Stichting REGMED XB
  • Minderbroedersberg 4-6, 6211 LK  Maastricht
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Connect with us

Copyright © 2021 RegMed XB. All rights reserved
Realisation & design by Joomlapartner